Find clinical trials for Pancreatic Cancer in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Philadelphia, PA, USA:
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
Philadelphia, Pennsylvania, United States and 12 other locations
control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins at the time of surgical tumor...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States of America and 4 other locations
A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...
Phase 2
Philadelphia, Pennsylvania, United States and 7 other locations
Antroquinonol is proposed for the treatment of neoplasms. The proposed clinical trial is a Phase I/II study designed to evaluate antroquinon ...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 8 other locations
in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 11 other locations
and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...
Phase 1
Philadelphia, Pennsylvania, United States and 17 other locations
compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...
Phase 2
Newark, Delaware, United States and 35 other locations
evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1 antibody-based SoC therapy in adult patients with solid tumors...
Phase 2
Mickleton, New Jersey, United States and 21 other locations
The study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma whic...
Phase 3
Camden, New Jersey, United States and 38 other locations
(with enzalutamide-naïve metastatic castration-resistant prostate cancer) will be randomized to receive either NUV-868 monotherapy, enzaluta...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 30 other locations
Clinical trials
Research sites
Resources
Legal